Related Experiment Video
Updated: Dec 25, 2025

Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
Environment-sensitive fluorescent inhibitors of histone deacetylase
Xin Zhou1, Gaopan Dong1, Tianjia Song1
1Department of Medicinal Chemistry, Key aboratory of Chemical Biology (MOE), School of Pharmacy, Shandong University, Jinan, Shandong 250012, China.
Abstract:
Histone deacetylases (HDACs) are proteases that can catalyze the deacetylation of histones to inhibit gene transcription. Since mutations and/or aberrant expression of various HDACs are frequently associated with human diseases, particularly cancers, HDACs are important therapeutic targets for many human tumors. However, there are still relatively few studies on HDAC small molecule fluorescent probes. Herein, we designed and synthesized a class of environment-sensitive fluorescent inhibitors with a switch mechanism to study HDAC activity. In vitro, the enzyme inhibition activity of compound 6b was comparable to the positive control drug SAHA, and it presented suitable imaging in living cells and tumor-tissue slices. This environment-sensitive fluorescent inhibitor provides a new idea for the diagnosis and treatment of HDACs-related diseases.
Insights
Researchers developed novel fluorescent probes to study histone deacetylases (HDACs), crucial targets in cancer. These probes show promise for diagnosing and treating HDAC-related diseases like cancer.
Area of Science:
- Biochemistry
- Molecular Biology
- Chemical Biology
Background:
- Histone deacetylases (HDACs) are enzymes implicated in gene regulation and are therapeutic targets for diseases, especially cancers.
- Aberrant expression or mutations in HDACs are linked to various human pathologies, underscoring their clinical significance.
- A limited number of small molecule fluorescent probes exist for studying HDAC activity.
Purpose of the Study:
- To design and synthesize novel environment-sensitive fluorescent inhibitors for studying histone deacetylase (HDAC) activity.
- To develop a switch-based mechanism for these fluorescent probes to enable activity-dependent imaging.
- To explore the potential of these probes for diagnosing and treating HDAC-related diseases.
Main Methods:
- Design and synthesis of a series of environment-sensitive fluorescent inhibitors targeting HDACs.
- Evaluation of enzyme inhibition activity of synthesized compounds in vitro, using SAHA as a positive control.
- Assessment of cellular and tissue imaging capabilities of the lead compound in living cells and tumor-tissue slices.
Main Results:
- Compound 6b demonstrated enzyme inhibition activity comparable to the positive control drug SAHA.
- The synthesized fluorescent inhibitor exhibited suitable imaging performance in both living cells and tumor-tissue slices.
- The environment-sensitive nature and switch mechanism of the probes were validated.
Conclusions:
- The developed environment-sensitive fluorescent inhibitors offer a new approach for studying HDAC activity.
- Compound 6b shows potential as a tool for the diagnosis and treatment of cancers and other HDAC-related diseases.
- This work provides a novel strategy for the development of fluorescent probes for enzyme activity monitoring.
More Related Videos
Related Concept Videos
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
Spreading of Chromatin Modifications
Writers
The writer...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Heterochromatin
Constitutive heterochromatin: It is a highly compact region of chromatin that is mostly concentrated in the centromere and telomere. Unlike euchromatin, the amino acid at...

